Looking beyond the leukemic cell for answers
Christopher Pepper et al.
Factors to consider in frontline and relapsed CLL before treatment
Inside the German CLL Study Group's annual workshop
Advances in the treatment of chronic lymphocytic leukemia
Drug combinations in CLL: ibrutinib, idelalisib and more